Anna Forrester
Calmare Therapeutics has received a contract modification to extend its 2010 agreement with the General Services Administration through the end of the first quarter of the company’s 2016 fiscal year.
The company said Wednesday the six-month extension covers the delivery of its pain mitigation therapy to military personnel who seek relief from chronic pain without the use of prescription drugs.
Conrad Mir, president and CEO of CTI, noted that the company continues to work toward a permanent deal to provide its services to the military.
CTI said its pain mitigation therapy aims to eventually eliminate chronic pain in sufferers for a year or more through an initial full treatment regimen and one or more booster treatments.
The company’s Calmare Pain Therapy device is available at U.S. military hospitals and clinics via its contract with GSA.
